Cargando…
Infección por SARS-CoV-2 y seroprevalencia en pacientes con esclerosis múltiple
INTRODUCTION: The effect of SARS-CoV-2 infection in patients with multiple sclerosis (MS) and the influence of disease-modifying therapies (DMT) for MS on COVID-19 are unknown. To date, patients with MS have not been shown to present greater risk of COVID-19 or more severe progression of the disease...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7973057/ https://www.ncbi.nlm.nih.gov/pubmed/33812762 http://dx.doi.org/10.1016/j.nrl.2021.03.005 |